Login / Signup

Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions.

Gytis DudasSamuel Leandro HongBarney I PotterSebastien Calvignac-SpencerFrédéric S Niatou-SingaThais B TombolomakoTerence Fuh-NebaUlrich VickosMarkus UlrichFabian Hubertus LeendertzKamran KhanCarmen HuberAlexander WattsIngrida OlendraitėJoost SnijderKim N WijnantAlexandre M J J BonvinPascale MartresSylvie BehillilAhidjo AyoubaMartin Foudi MaidadiDowbiss Meta DjomsiCelestin GodweChristelle ButelAistis ŠimaitisMigle GabrielaiteMonika KatėnaitėRimvydas NorvilasLigita RaugaitėGiscard Wilfried KoyawedaJephté Kaleb KandouRimvydas JonikasInga NasvytienėŽivilė ŽemeckienėDovydas GečysKamilė TamušauskaitėMilda NorkienėEmilija VasiliūnaitėDanguolė ŽiogienėAlbertas TiminskasMarius ŠukysMantas ŠarauskasGediminas AlzbutasAdrienne Amuri AzizaEddy Kinganda LusamakiJean-Claude Makangara CigoloFrancisca Muyembe MaweteEmmanuel Lokilo LofikoPlacide Mbala KingebeniJean-Jacques Muyembe TamfumMarie Roseline Darnycka BelizaireRené Ghislain EssombaMarie Claire Okomo AssoumouAkenji Blaise MboringongAlle Baba DiengDovilė JuozapaitėSalome HoschJustino ObamaMitoha Ondo'o AyekabaDaniel NaumovasArnoldas PautieniusClotaire Donatien RafaïAstra VitkauskienėRasa UgenskienėAlma GedvilaitėDarius ČereškevičiusVaiva LesauskaitėLukas ŽemaitisLaimonas GriškevičiusGuy Baele
Published in: Nature communications (2021)
Distinct SARS-CoV-2 lineages, discovered through various genomic surveillance initiatives, have emerged during the pandemic following unprecedented reductions in worldwide human mobility. We here describe a SARS-CoV-2 lineage - designated B.1.620 - discovered in Lithuania and carrying many mutations and deletions in the spike protein shared with widespread variants of concern (VOCs), including E484K, S477N and deletions HV69Δ, Y144Δ, and LLA241/243Δ. As well as documenting the suite of mutations this lineage carries, we also describe its potential to be resistant to neutralising antibodies, accompanying travel histories for a subset of European cases, evidence of local B.1.620 transmission in Europe with a focus on Lithuania, and significance of its prevalence in Central Africa owing to recent genome sequencing efforts there. We make a case for its likely Central African origin using advanced phylogeographic inference methodologies incorporating recorded travel histories of infected travellers.
Keyphrases
  • sars cov
  • single cell
  • respiratory syndrome coronavirus
  • endothelial cells
  • copy number
  • quality improvement
  • public health
  • risk factors
  • cell fate
  • genome wide
  • binding protein
  • infectious diseases